US In-Vitro Diagnostic Substance Market - Forecasts & Trends (2017-2025)

IndexBox has just published a new report "U.S. In-Vitro Diagnostic Substances Market. Analysis And Forecast to 2025" ( http://www.indexbox.co.uk/store/us-in-vitro-diagnostic-substances-market-analysis-and-forecast-to-2020?utm_source=opr ).

This report is best suitable for you if you:
• Are planning to enter a new geographical market and wish to know which one is best for your product
• Are planning to enter a new product market and want to have a detailed overview of the market before entering
• Already work in a given market and want to update your knowledge on the topic
• Are developing/reviewing your company strategy and wish to know the existing trends in the market
• Want to find the best country to import a product from
• Are consulting a client in the given industry and wish to get a deep understanding of the situation in the market
• Are planning to open new production facilities and wish to choose the best location.

The report serves the above mentioned purposes by providing a deep survey of the key indicators of the in-vitro diagnostic substance market. It includes a market overview, which consolidates the key conclusions made from the analysis of the market survey, giving insights on the most influential markets based on the comparative analysis. The report also provides a outlook of how the market is expected to change in the coming years, based on historical trends, external and internal factors, and the main drivers changing the market. Each section contains a an in-depth survey of the data provided. Specifically, the report reveals the historical developments and existing projections of in-vitro diagnostic substance production volumes, consumption data, as well as producer prices.
The trade section provides crucial data, such as historical data on imports/exports, changes in the direction of trade, as well as import/export prices. Analysis of in-vitro diagnostic substance trade shows the opportunities that are opening before producers and suppliers in a changing market.

Product coverage: In-vitro diagnostic substances.

Countries coverage: the U.S.

Abstract:
In 2015, the value of in-vitro diagnostic substance production in the U.S. amounted to $11.7B, rising by +4.8% against the previous year level. Overall, the U.S. in-vitro diagnostic substance output pursued a considerable growth from 2007 to 2015. The total output figures increased at an average annual rate of +3.4%. The trend pattern, however, indicated some noticable fluctuations throughout the analyzed period. The growth pace was the most rapid in 2010, when the output figure increased by +25% from the previous year level. Over the period under review, the total value of in-vitro diagnostic substance shipments in the United States attained its maximum level of $12.0B in 2013. Afterwards, the growth in terms of the in-vitro diagnostic substance production failed to regain its strength through to 2015.

Data coverage:
• In-vitro diagnostic substance market value and size;
• Major trends in the in-vitro diagnostic substance market;
• Forecast of the market dynamics in the medium term;
• Exports, imports and trade balance;
• Import and export prices;
• Life cycle of the in-vitro diagnostic substance industry;
• Number of establishments and their locations;
• In-vitro diagnostic substance industry productivity.
• Key market players and their profiles.

Methodology:
Our methodology consists of obtaining information from various trusted sources (both paid and open), which include, but are not limited to:
• International official statistical agencies
• Governmental statistical agencies
• Official trade statistics
• Paid trade databases
• Industrial associations
• Company reports
• Industry experts.

Companies mentioned:
Abbott Diabetes Care,
Orasure Technologies,
Amag Pharmaceuticals,
Streck, Diasorin Inc.,
Diadexus,
Rapid Pathogen Screening,
Maine Biotechnology Services,
Saladax Biomedical,
Corgenix Medical Corporation,
George King Bio-Medical,
Princeton Biomeditech Corp,
Banyan Biomarkers,
Anatech,
Dxna LLC,
CD Diagnostics,
Akers Biosciences,
Helica Biosystems,
Green Mountain Antibodies,
Biospacific, Innominata,
Phase 2 Discovery,
Immuno Concepts,
Hepatochem,
Lifecare Medical International,
Horizon Diagnostic,
Immucor Gti Diagnostics,
Werfen USA,
Ivd Intermediate Holdings B Inc.,
Opko Diagnostics,
Horizon Diagnostic Inc,
Immucor Gti Diagnostics,
Werfen USA,
Ivd Intermediate Holdings B Inc.,
Opko Diagnostics

Our research team compare the information gathered, confirm it with sources when required, and analyze the collected data, developing a full clear picture of the market and coming up with the final numbers. It is crucial to understand the trends of the market, for which we do provide study, taking into account events in the market, in adjacent and related markets, raw material markets, and markets, which are the main demand creators for the product under research. As for the forecast, it is conducted using analytical models of data on consumption, production, exports, imports, prices, as well as the industry trends, economic trends, consumption trends, possible political and technological trends.

Source: http://www.indexbox.co.uk/store/us-in-vitro-diagnostic-substances-market-analysis-and-forecast-to-2020?utm_source=opr

IndexBox is a leading market research publisher in the world. You can find more than 25,000 research reports in our web store, which cover global industries and regional markets. All the worldwide marketing data you need is at your fingertips.

Company Name: IndexBox
Contact Person: Kirill Bezverhi
Email: kirill.bezverhi@indexbox.co.uk
Phone: +44 20 3239 3063
Adress: United Kingdom, 44 Main Street, Douglas, South Lanarkshire, Scotland, ML11 0QW

This release was published on openPR.